Home › Type 1 Diabetes › NCT07059806
T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes
T1CARE: A Randomized Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes
Who can join
Ages 18 to 40 · All sexes
Full eligibility criteria
Inclusion Criteria: * Type 1 Diabetes * fluent in Spanish or English who reside in the greater New Haven area Exclusion Criteria: * cognitive impairment and otherwise unable to give written informed consent about participating in this study
About the study
Randomized controlled trial with a wait list control arm. Participants will be randomized 1:1 to T1CARE or wait list usual care arm. Participants will be recruited from the Yale Adult and Pediatric Diabetes Centers. Patients assigned to T1CARE will receive support from a Community Health Navigator at Project Access-New Haven.
What is being tested
- T1CARE (behavioral)
Sponsor: Yale University · Participants: 100 · Started: Sep 5, 2025
Contact the study team
- Kasia J Lipska, MD · Phone: 203-500-3053
Official record on ClinicalTrials.gov — NCT07059806
Locations in the U.S.
| Connecticut | Yale Adult Diabetes Center, New Haven Yale Children's Diabetes Center, New Haven |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.